{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/169294539"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "FDA. Actual results may differ materially from those set forth in this press release due to the risks and uncertainties inherent in our business, including whether successful clinical and regulatory development and review and approval of HEPLISAV" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "dynavax.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/462719990"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/169294539" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/103569446"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/169294539"] } } }
